Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Maternal lipid profile and risk of pre-eclampsia in African pregnant women: A systematic review and meta-analysis

  • Endalamaw Tesfa ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

    endalamaw2009@gmail.com, endalamaw.tesfa@bdu.edu.et

    Affiliations Department of Biochemistry, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia, Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia

    ⨯
  • Endalkachew Nibret,

    Roles Formal analysis, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliations Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia, Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia

    ⨯
  • Abaineh Munshea

    Roles Investigation, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliations Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia, Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia

    ⨯

Abstract

Introduction

Some studies have reported the association between maternal serum lipid profile abnormalities and pre-eclampsia. However, many studies have reported controversial results. Hence, this systematic review and meta-analysis was planned to generate summarized evidence on the association between maternal serum lipid profiles and pre-eclampsia in African women.

Methods

Four electronic databases such as; PubMed, Hinari, Google Scholar, and African Journals Online were searched for studies published in English. Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument and Newcastle-Ottawa Scale were used for data extraction and quality assessment of the included studies. The meta- regression analysis was performed by Stata 14 software. The standardized mean difference (SMD) values of lipid profiles were computed to assess their association with pre-eclampsia at 95% CI.

Results

In this review a total of 15 observational studies were included. The mean values of triglyceride (TG), total cholesterol (TC), low density lipoprotein- cholesterol (LDL-c) and very low density lipoprotein- cholesterol (VLDL-c) were significantly higher in pre-eclamptic women as compared with normotensive pregnant women (TG = 229.61±88.27 and 147.00 ± 40.47, TC = 221.46 ± 45.90 and 189.67 ± 39.18, LDL = 133.92 ± 38.77 and 112.41 ± 36.08, VLDL = 41.44 ± 19.68 and 26.64 ± 7.87), respectively. The serum high density lipoprotein cholesterol (HDL-c) level was lower, but it is not statistically significant (HDL-c = 51.02 ± 16.01 and 61.80 ± 25.63) in pre-eclamptic women as compared with controls. The pooled standardized mean difference (SMD) of TG, TC, LDL-C and VLDL-C were significantly increased in pre-eclamptic women as compared with normotensive pregnant women with the SMD of (TG = 1.65 (1.10, 2.21), TC = 0.84 (0.40, 1.29), LDL-C = 0.95 (0.46, 1.45) and VLDL-C = 1.27 (0.72, 1.81)) at 95% CI, respectively, but the pooled SMD of HDL-cholesterol was decreased in pre-eclamptic women as compared with normotensive pregnant women (SMD = -0.91 (95% CI: -1.43, -0.39).

Conclusions

In this review, the maternal serum levels of TG, TC, LDL-c and VLDL-c were significantly associated with the risk of preeclampsia. However, HDL- cholesterol was not significantly associated but it was lower in pre-eclamptic women. Further, large scale prospective studies should verify these outcomes and it is recommended that lipid profiles should be included as a routine diagnostic test for pre-eclamptic women.

Citation: Tesfa E, Nibret E, Munshea A (2020) Maternal lipid profile and risk of pre-eclampsia in African pregnant women: A systematic review and meta-analysis. PLoS ONE 15(12): e0243538. https://doi.org/10.1371/journal.pone.0243538

Editor: Frank T. Spradley, University of Mississippi Medical Center, UNITED STATES

Received: September 5, 2020; Accepted: November 23, 2020; Published: December 23, 2020

Copyright: © 2020 Tesfa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and in the supporting Information files.

Funding: There is no funding organization and we did not receive any fund for this study.

Competing interests: the authors have declared that no competing interests exist.

Abbreviations: BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; GA, gestational age; HDL, high density lipoprotein; JBI, MAStARI, Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument; LDL, low density lipoprotein; NOS, Newcastle-Ottawa Scale; PE, Pre-eclampsia; PRISMA, preferred reporting items for systematic reviews and meta-analyses; RR, risk ratio; SBP, systolic blood pressure; SD, Standard Deviation; SEM, standard error of Mean; SMD, standardized mean difference; TC, total cholesterol; TG, triglycerides and VLDL, very low density lipoprotein

1. Introduction

Pre-eclampsia is a pregnancy related metabolic syndrome characterized by hypertension and proteinuria occurred after 20 weeks of gestation. It is the most common cause of maternal and prenatal morbidity and mortality [1]. The cause of pre-eclampsia is not clearly known, but failure of spiral artery remodeling cause’s placental ischemia and maternal syndrome resulted in hypertension and proteinuria [2]. Increased in lipid oxidation products and decreased in the levels of antioxidants involved in the pathogenesis of pre-eclampsia [3]. Different reports showed that the risk of pre-eclampsia increases in the women with higher levels of oxidized low-density lipoprotein (LDL) and triglycerides (TG) and lower levels of circulating vitamin C as compared to normotensive pregnant women [4, 5]. The oxidative conversion of LDL- cholesterol to oxidized LDL form is the key event for the initiation and development of atherosclerosis and hypertension [4].

Early pregnancy dyslipidemia is associated with an increased risk of pre-eclampsia [1]. In the early pregnancy, the mother exists in the anabolic state and the lipid serves as a source of calories for the growing fetus as well as for the mother in the third trimester [6]. There are many facts that show lipid profile abnormalities might be associated with the risk of pre-eclampsia. Lipid profiles such as: TG, LDL-c, total cholesterol (TC) and very low density lipoprotein (VLDL) levels are higher in pre-eclamptic women as compared with normal pregnancies, but high-density lipoprotein (HDL) level is lower in pre-eclamptic women as compared with normal pregnancies [7–9]. Lipid profile abnormalities increases as the gestational age of the mother increases. A meta-analysis study consisted of 24 case control studies confirmed that there is a strong association between hypertriglyceridemia and the risk of pre-eclampsia [10].

Different studies have tried to elucidate the association between the maternal serum lipid profiles and pre-eclampsia, but many of them have reported conflicting results. Some studies have shown higher levels of lipid profiles in pre-eclamptic women as compared to normotensive pregnant women [9, 11–13]. However, a few studies have found non-significant difference in the serum levels of maternal lipid profiles between pre-eclamptic and normotensive pregnant women [14, 15] and few other reports indicated lower serum lipid profiles in pre-eclamptic women as compared to normotensive controls. Therefore, this systematic review and meta-analysis was designed to generate summarized evidence between maternal serum lipid profiles and risks of pre-eclampsia in African pregnant women.

2. Methods and materials

2.1. Protocol and registration

This review protocol is registered at the National Institute for Health Research; PROSPERO international prospective register of systematic reviews with registration number CRD42020192865 at (https://www.crd.york.ac.uk/prospero/#recordDetails).

2.2. Study design and search strategy

A systematic review and meta-analysis of published studies was conducted to assess the association between maternal serum lipid profiles and risk of pre-eclampsia in African pregnant women. We searched for the following databases: PubMed, Hinari, African Journals Online (AJOL) and Google Scholar. The search was done by using the following Medical Subject Heading (MeSH) terms; “Lipids, Triglycerides, Cholesterol, HDL, VLDL, LDL, Pre-eclampsia and Africa” separately or in combination by using string term Or AND. All published and unpublished articles up-to July 30, 2020 were retrieved and assessed for their eligibility for their inclusion in this review. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline was utilized to conduct this systematic review and meta-analysis.

2.3. Eligibility criteria

Inclusion and exclusion criteria;

  1. Studies conducted on human subjects were included.
  2. Studies with case-control, cross-sectional and cohort designs in Africa were included.
  3. Articles that report pre-eclampsia as an outcome variable were included.
  4. Published and unpublished articles written in English were included.
  5. Studies considering lipid profiles as the determinant variable and reporting the result in mean and standard deviation were included.
  6. Studies conducted in the community or in the health institution were included.
  7. Conference papers, editorials, reviews and randomized control trials were excluded.

2.4. Study selection and screening

All citations identified by our search strategy were exported to EndNote -X9- and duplicate articles were removed. And then the titles and abstracts of the identified articles were screened by two independent reviewers, and eligible studies were included for further review. The full texts of selected articles were retrieved and read thoroughly to ascertain the suitability prior to data extraction. In case of disagreement between the two reviewers, discussion was held to reach consensus and the third reviewer was consulted. The search process was presented in PRISMA flow chart that clearly shows the studies that were included and excluded with reasons of exclusion (Fig 1) [16].

thumbnail
Download:
Fig 1. Flow diagram showing the included studies for the systematic review and meta-analysis of maternal lipid profile and pre-eclampsia.

https://doi.org/10.1371/journal.pone.0243538.g001

2.5. Definition of outcome interest

The primary outcome of this study is to evaluate the association between maternal serum lipid profiles with the risk of pre-eclampsia in African pregnant women.

  • Hypertension is defined as the systolic blood pressure ≥140mmHg and/or diastolic ≥90mmHg that are measured at least two times within four hours interval.
  • Proteinuria: urinary protein excretion of ≥300mg /24-h urine sample or ≥1+ on qualitative dipstick examination or a total protein: creatinine ratio ≥30 mg/ mmol (or ≥0.3 when both are measured in mg/dL).
  • Gestational hypertension: hypertension diagnosed after 20 weeks of gestation.
  • Pre-eclampsia is defined as hypertension plus proteinuria after 20 weeks of gestation.
  • Eclampsia: Seizures in women with hypertension that cannot be attributed to other causes [17].

2.6. Quality assessment

For case-control and cohort studies, we used Newcastle-Ottawa Scale (NOS) to assess the quality of the included studies while for cross sectional studies the modified version of NOS was used to assess the quality of the studies for inclusion [18]. The NOS included 3 categorical criteria with a maximum score of 9 points. The quality of each study was rated using the following scoring algorithms: ≥7 points was considered as “Good”, 4 to 6 points was considered as “Fair”, and ≤3 point was considered as “Poor” quality study. In order to improve the validity of the review result, we only included primary studies with fair to good quality [18].

2.7. Data extraction process

The data extraction was done using a tool developed by the 2014 Joanna Briggs Institute Reviewers’ Manual data extraction form [19]. The abstract and full-text were reviewed by the two independent reviewers. Data extraction includes: author’s name, publication year, study country, study design, sample size, number of cases and controls, mean age, mean gestational age, mean BMI, mean SBP and DBP, mean TG, TC, HDL, LDL and VLDL levels were extracted. Standard error of mean (SEM) was computed by the formula SEM = SD/√n. Lipid profiles measured in mmol/L was converted into mg/dL by multiplying their conversion factors. For few studies that didn’t report VLDL value we estimated from TG level by dividing into five.

2.8. Data analysis

The data were entered into Microsoft excel and the meta-analysis was performed using Stata 14 software and SPSS version 20. Forest plot of standardized mean difference (SMD) were used to assess the effect size between the serum levels of lipid profiles and pre-eclampsia at 95% CI. The SMD is the ratio of the mean difference to the pooled standard deviation. Standard error of mean (SEM) was also computed by dividing standard deviation to the square root of the sample size. Subgroup analysis was done by country (Nigeria, Ghana and Egypt). Variables including; maternal age, gestational age, BMI, mean lipid profiles were assessed through paired sample test to know their difference among pre-eclamptic and normotensive pregnant women.

2.9. Heterogeneity and publication bias

Statistical heterogeneity was estimated through Cochrane Q, I2 statistic and P-value. If I2 statistic values < 25%, 25–50%, and ≥50% were used to declare the heterogeneity test as low, medium and high, respectively. In this review, a random effect model (REM) was used for analysis. To cope with the reasons of high heterogeneity subgroup analysis and sensitivity test were performed. Publication bias was assessed through funnel plot and Egger’s test.

3. Results

3.1. Study selection

A total of 537 articles were retrieved through electronic search by using different search terms of which 454 article were eligible for title and abstract assessment after removal of 83 duplicate records. Out of 454 articles screened for eligibility 414 records were excluded after assessing their title and abstract. A total of 40 articles underwent full- text assessment, 25 studies were excluded due to different reasons (21 articles were done outside the study area and four articles didn’t report outcome variable).

3.2. Study characteristics

In this review a total of 15 studies were included. Ten of them were case-control and three studies were Cross-sectional and the other two were cohort. Studies that have been conducted in Africa up- to July 30, 2020 were included. Ten studies were conducted in Nigeria and the other three and two studies were conducted in Ghana and Egypt respectively. In this review a total of 2,106 pregnant women were included (828 cases and 1, 273 controls) (Table 1).

thumbnail
Download:
Table 1. Characteristics of research articles included in the systematic review and meta-analysis (N = 15).

https://doi.org/10.1371/journal.pone.0243538.t001

3.3. Association of different variables with pre-eclampsia

In this analysis, we compared the mean values of variables among preeclamptic and normal pregnant women. Statistical significant difference was not observed between the two groups in regards to the mean values of maternal age, and gestational age. However, statistical significant difference were observed in the mean values of systolic blood pressure (SBP), diastolic blood pressure (DBP), TC, TG, LDL-C and VLDL-C levels between preeclamptic and normotensive pregnant women (Table 2).

thumbnail
Download:
Table 2. Paired sample test analysis of variables in PE and normotensive pregnant women.

https://doi.org/10.1371/journal.pone.0243538.t002

3.4. Association of serum total cholesterol with pre-eclampsia

In this sub-categorical analysis 15 studies were included to compare the serum levels of total cholesterol between pre-eclampsia and normotensive pregnant women [12, 14, 15, 20–31]. Eight of the included studies [12, 22, 24–26, 29–31] reported significantly higher serum levels of total cholesterol in pre-eclamptic women. Although, seven studies were showed non-significant association between the serum levels of total cholesterol and pre-eclampsia [14, 15, 20, 21, 23, 27, 28]. The pooled meta-regression analysis showed that there is a statistical significant association between total cholesterol and pre-eclampsia as compared with normotensive pregnant women with the pooled SMD of 0.84 (95% CI: 0.40, 1.29) (Fig 2).

thumbnail
Download:
Fig 2. Forest plot of standardized mean difference of total cholesterol and pre-eclampsia.

https://doi.org/10.1371/journal.pone.0243538.g002

3.5. Association of serum triglycerides with pre-eclampsia

In this sub-categorical analysis 15 studies were included to compare the serum triglyceride levels between pre-eclamptic and normotensive pregnant women [12, 14, 15, 20–31]. Thirteen of the included studies [12, 20–31] showed significantly higher serum triglyceride level in pre-eclamptic group as compared with normotensive pregnant women but two studies did not show significant association between serum triglyceride level and pre-eclampsia [14, 15]. The pooled meta-regression analysis showed that there is a statistical significant association between serum levels of triglycerides and pre-eclampsia as compared to normotensive pregnant women with the pooled SMD of 1.65 (95% CI: 1.10, 2.21) (Fig 3).

thumbnail
Download:
Fig 3. Forest plot of standardized mean difference of total triglycerides and pre-eclampsia.

https://doi.org/10.1371/journal.pone.0243538.g003

3.6. Association of serum HDL-cholesterol with pre-eclampsia

In this sub-categorical analysis 15 studies were included to compare the serum HDL-c levels between pre-eclamptic and normotensive pregnant women [12, 14, 15, 20–31]. Nine of the included studies [12, 15, 20, 21, 25, 26, 28, 30, 31] showed significantly lower levels of serum HDL-c and three studies [22, 24, 27] showed higher levels of serum HDL-c in pre-eclamptic group as compared to normotensive pregnant women but, three studies [14, 23, 29] did not show a significant association between serum HDL-c and pre-eclampsia. The pooled meta-regression analysis showed that there is a statistical significant association between serum levels of HDL-c and pre-eclampsia as compared to normotensive pregnant women with the pooled SMD of -0.91 (95% CI: -1.43, -0.39) (Fig 4).

thumbnail
Download:
Fig 4. Forest plot of standardized mean difference of HDL-cholesterol and pre-eclampsia.

https://doi.org/10.1371/journal.pone.0243538.g004

3.7. Association of serum LDL-cholesterol with pre-eclampsia

In this sub-categorical analysis 15 studies were included to compare the serum LDL-cholesterol levels between pre-eclamptic and normotensive pregnant women [12, 14, 15, 20–31]. Nine of the included studies [12, 20–22, 24–26, 29, 31] showed significantly higher serum levels of LDL-c in pre-eclamptic group, but six studies didn’t show significant association between serum levels of LDL-c and pre-eclampsia [14, 15, 23, 27, 28, 30]. The pooled meta-regression analysis showed that there is a statistical significant association between the serum levels of LDL-c and pre-eclampsia as compared to normotensive pregnant women with the pooled SMD of 0.95 (95% CI: 0.46, 1.45) (Fig 5).

thumbnail
Download:
Fig 5. Forest plot of standardized mean difference of LDL-cholesterol and pre-eclampsia.

https://doi.org/10.1371/journal.pone.0243538.g005

3.8. Association of serum VLDL-cholesterol with pre-eclampsia

In this sub-categorical analysis 15 studies were included to compare the serum level of VLDL-c between pre-eclampsia and normotensive pregnant women [12, 14, 15, 20–31]. Twelve studies [12, 21–31] showed significantly higher serum levels of VLDL-c in pre-eclampsia whereas one study [20] showed lower level of serum VLDL-c in pre-eclampsia. Although, two studies [14, 15] did not show significant association between the serum level of VLDL- c and pre-eclampsia. Pooled meta-regression analysis showed that there is a statistical significant association between the serum levels of VLDL-c and pre-eclampsia as compared to normotensive pregnant women with a pooled SMD of 1.27 (95% CI: 0.72, 1.81) (Fig 6).

thumbnail
Download:
Fig 6. Forest plot of standardized mean difference of VLDL-cholesterol and pre-eclampsia.

https://doi.org/10.1371/journal.pone.0243538.g006

3.9. Sensitivity analysis and publication bias

A sensitivity test was done by omitting one study at a time to assess the stability of the results. There was no significant change in the pooled SMD after excluding one of the studies at 95% CI. This means there is no individual study that excessively influences the pooled effects of the serum lipid profiles in pre-eclamptic women (S2 File). Due to the presence of high statistical heterogeneity random effect model was used for analysis. To sort out the cause heterogeneity, publication bias was assessed by funnel plot and Egger’s test. Funnel plot and Egger’s test didn’t show evidence of publication bias between the serum levels of lipid profile and the risks of pre-eclampsia (S3 File). However, the Egger’s test of LDL-cholesterol shows the presence of possible publication bias (p = 0.010). This bias might be due to missing of grey literatures and exclusion of non-English language articles.

4. Discussion

This study is the first systematic review and meta-analysis in African pregnant women which provides information on the association of maternal serum lipid profiles with pre-eclampsia. In this study, maternal age and gestational age were comparable between the two groups and these variables didn’t show a statistical significant association with pre-eclampsia. The mean BMI, systolic and diastolic blood pressure measurements were significantly different among pre-eclamptic and normotensive pregnant women.

The cause of pre-eclampsia is not well understood but it is believed that reduced uteroplacental perfusion as a result of abnormal spiral artery remodeling causes the disease. Placental ischemia causes an increased synthesis of endothelin, thromboxane and different chemical mediators which affects the endothelium and resulted maternal syndromes [32]. It is a known fact that lipid metabolism is markedly changed during pregnancy and dyslipidemia involved in the pathogenesis of pre-eclampsia [33]. There are different serum lipid biomarkers that predict the risk of pre-eclampsia in pregnant women [34]. In the early pregnancy, the mother stayed in anabolic state but in the late pregnancy the mother is in the catabolic state which leads to an increased in the concentration of plasma free fatty acids and glucose level due to insulin resistance [6]. The plasma lipid levels are increased due to hormonal changes and the problem worsens as the gestational age increases [35].

In this review, we found that the mean serum total cholesterol level was significantly higher in preeclamptic women as compared to normotensive pregnant women (221.84 ± 47.61 and 190.43 ± 40.55), respectively and its pooled SMD was (SMD = 0.82, 95% CI: 0.35, 1.29). Similar results were reported in the studies conducted in China and India [36, 37]. The plasma cholesterol level increases during pregnancy in response to an increase estrogen induced hepatic synthesis or failure of lipoprotein lipase to clear the plasma lipids. Higher plasma cholesterol level is used for placental steroid, placental membrane synthesis and stored as maternal fat store which served as a fuel for the mother as well as for the growing fetus in later pregnancy or during lactation [35, 36].

The mean serum triglyceride level of the current study was significantly higher in preeclamptic women than normotensive pregnant women (228.04 ± 91.38 and 145.67 ± 121.61), respectively and its pooled SMD was (SMD = 1.61, 95% CI: 1.03, 2.14). Similar, findings were reported in the studies conducted in China and Pakistan [36, 38, 39]. In the prospective cohort study conducted in Netherlands, hypertriglyceridemia were associated with pre-eclampsia and high blood pressure in the early pregnancy [40]. During the course of pregnancy the levels of triglyceride is also increases in response to estrogen and hepatic lipase activity. Additionally, a reduced lipoprotein lipase enzyme activity and insulin resistance leads to decrease in lipid catabolism at the tissue level which causes hypertriglyceridemia [41, 42]. Hypertriglyceridemia is an important risk factor for cardiovascular disease (CVD), hypertension, diabetes and metabolic syndrome in obese and insulin resistant persons [43].

In this review, we found that the mean serum HDL-c level was lower in preeclamptic women as compared to normotensive pregnant women (51.62 ± 16.44 and 62.74 ± 26.33), respectively and its pooled SMD was (SMD = -0.89, 95% CI: -1.43, -0.35). Similar findings were reported in the studies conducted in Nigeria and China [21, 36]. Reports showed that reduced levels of HDL-c being associated with an increased risk of coronary disease and myocardial infarction [44]. HDL carries cholesterol from peripheral tissues to the liver, where it is broken down for excretion and used for synthesis of biomolecules. Higher levels of HDL lipoprotein have protective effect against hypertension and cardiovascular diseases [45].

In the current study, we found that the mean serum LDL-cholesterol level was significantly higher in preeclamptic women than normotensive pregnant women (139.12 ± 34.38 and 116.43 ± 33.77), respectively and its pooled SMD was (SMD = 0.95, 95% CI: 0.46, 1.45). Similar, evidences were reported in the studies conducted in China, Bangladesh and Nigeria [21, 36, 46]. LDL-c transports cholesterol to the peripheral tissue and plays significant role in the development of atherosclerosis and cardiovascular disease [47]. The oxidized LDL products modify the lysine residues of Apo-lipoprotein B (apo B) which is recognized by the receptors of macrophages. The modified product of LDL is engulfed by macrophages and converted into foam cells which induce production of different inflammatory mediators resulted in plaque formation and atherosclerosis [48].

In this review, we found that the mean serum VLDL-cholesterol level was significantly higher in preeclamptic women than normotensive pregnant women (40.81 ± 20.26 and 26.18 ± 7.96), respectively and its pooled SMD was (SMD = 1.27, 95% CI: (0.72, 1.81)). Similar finding were reported in the studies conducted in China and Nigeria [21, 36]. VLDL cholesterol carries the highest amount of triglycerides from the liver to the blood vessels which have been linked to atherosclerosis and the subsequent risk of heart diseases and stroke [45]. VLDL cholesterol remnants are associated with the risk of pre-eclampsia and high blood pressure [40]. VLDL and LDL cholesterol are known as bad lipoprotein to due to an increased risk of atherosclerosis. Experts suggested that lower levels of VLDL and LDL cholesterol and higher levels of HDL cholesterol are beneficial for the prevention of chronic diseases.

5. Strength and limitation

Strength

This systematic review and meta-analysis generated pooled data showing lipid profiles and risk of pre-eclampsia in African women. In addition, this review serves as baseline information for further study.

Limitation

The search strategy was limited to articles published in English, and this could lead to reporting bias. We include small number of studies and most of them were from Nigeria, and this may influence its generalizability to African women. Moreover, presence of high statistical heterogeneity among the included studies would decrease the generalization of evidence from this review.

6. Conclusion

In this systematic review and meta-analysis the mean serum lipid profiles were significantly higher in pre-eclamptic women than in normotensive pregnant women. The pooled standardized mean difference of serum lipid profiles such as: total cholesterol, triglyceride, LDL-cholesterol, and VLDL-Cholesterol were significantly higher in pre-eclamptic women than normotensive pregnant women but HDL-cholesterol was lower in preeclamptic women. Thus, we conclude that dyslipidemia could play certain roles in the pathogenesis of pre-eclampsia. However, concrete evidence on the roles of dyslipidemia in pre-eclampsia in African pregnant women should require large scale prospective studies.

References

  1. 1. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA: Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004, 17(7):574–581. pmid:15233976
  2. 2. Raijmakers MT, Dechend R, Poston L: Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 2004, 44(4):374–380. pmid:15326082
  3. 3. Gupta S, Aziz N, Sekhon L, Agarwal R, Mansour G, Li J, et al.: Lipid Peroxidation and Antioxidant Status in Preeclampsia A Systematic Review. OBSTETRICAL AND GYNECOLOGICAL SURVEY 2009, 64(11):750–759. pmid:19849867
  4. 4. Qiu C, Phung TTT, Vadachkoria S, Muy-Rivera M, Sanchez SE, Williams MA: Oxidized Low-Density Lipoprotein (Oxidized LDL) and the Risk of Preeclampsia. Physiol Res 2006, 55:491–500. pmid:16343047
  5. 5. Timalsina S, Gyawali P, Bhattarai A: Comparison of lipid profile parameters and oxidized low-density lipoprotein between normal and preeclamptic pregnancies in a tertiary care hospital in Nepal. Int J Womens Health 2016, 8:627–631. pmid:27822126
  6. 6. Lain KY, Catalano PM: Metabolic Changes in Pregnancy. CLINICAL OBSTETRICS AND GYNECOLOGY 2017, 50(4):938–948.
  7. 7. Baker AM, Klein RL, Moss KL, Haeri S, Boggess K: Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 2009, 201(3):293 e291–294.
  8. 8. De J, Mukhopadhyay AK, Saha PK: Study of serum lipid profiles in Pregnancy Induced Hypertension Indian Journal of Clinical Biochemistry, 2006, 21(2):165–168. pmid:23105637
  9. 9. Thathagari V, C. M VK: Evaluation of serum lipids in preeclampsia: a comparative study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2018, 7(4).
  10. 10. Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S, Vatish M: Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG: an international journal of obstetrics and gynaecology 2013, 120(11):1321–1332.
  11. 11. Agarwal V, Gupta BK, Vishnu A, Mamtatyagi , Shiprasolanki , Kiran J: Association of Lipid Profile and Uric Acid with Pre-eclampsia of Third Trimester in Nullipara Women. J Clin Diagn Res 2014, 8(7):CC04–07. pmid:25177559
  12. 12. Ahmed AAM, El Omda FAA, Mousa MSM: Maternal Lipid Profile as A Risk Factor for Preeclampsia. The Egyptian Journal of Hospital Medicine 2018, 71(6):3434–3438.
  13. 13. Baumfeld Y, Novack L, Wiznitzer A, Sheiner E, Henkin Y, Sherf M, et al.: Pre-Conception Dyslipidemia Is Associated with Development of Preeclampsia and Gestational Diabetes Mellitus. PloS one 2015, 10(10):e0139164. pmid:26452270
  14. 14. Yeboah FA, Ngala RA, Bawah AT, Asare-Anane H, Alidu H, Hamid AM, et al.: Adiposity and hyperleptinemia during the first trimester among pregnant women with preeclampsia. Int J Womens Health 2017, 9:449–454. pmid:28670144
  15. 15. Vanderjagt DJ, Patel RJ, EL-Nafaty AU, Melah GS, Crossey MJ, Glew R, H.: High-density lipoprotein and homocysteine levels correlate inversely in preeclamptic womeninnorthernNigeria. Acta obstetricia et gynecologica Scandinavica Supplement 2004, 83:536–542. pmid:15144334
  16. 16. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097. pmid:19621072
  17. 17. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R: Pre-eclampsia part 1: current understanding of its pathophysiology. Nature reviews Nephrology 2014, 10(8):466–480. pmid:25003615
  18. 18. Hartling L, Milne A, Hamm MP, Vandermeer B, Ansari M, Tsertsvadze A, et al.: Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. Journal of clinical epidemiology 2013, 66(9):982–993. pmid:23683848
  19. 19. Institute JB: Joanna Briggs Institute Reviewers’ Manual: 2014 edition / Supplement. Joanna Briggs Institute 2014.
  20. 20. Ahenkorah L, Owiredu WKBA, Laing EF, Turipin CA: Lipid profiles and Lipid Peroxidation among Ghanian Pregnancy Induced Hypertensives. J Med Sci, 2008, 8(8):691–698.
  21. 21. Avidime AR, Tella MA, Hadiza G, Abiodun OO: A comparative Study of Serum Lipid Levels in PreEclamptic and Normotensive Pregnant Women in a Tertiary Hospital, Northwest Nigeria. Biomed J Sci & Tech Res 2018, 3(1):3003–3011. pmid:32200955
  22. 22. Olalere FDH, Okusanya BO, Oye-Adeniran BA: Maternal serum lipid in women with preeclampsia in Lagos: a case control study. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2020, 33(5):794–798. pmid:30176753
  23. 23. Njoku TK: Evaluation of serum lipid profile in women with Pre-eclampsia in Federal Medical Center, Owerri: A case control study. Unpublished 2017:1–34.
  24. 24. Nwachukwu KC: Study of serum lipids and lipoprotein profile of pre-eclamptic in umuahia, Southeast Nigeria. Unpublished 2017:1–52.
  25. 25. El Khouly NI, Sanad ZF, Saleh SA, Shabana AA, Elhalaby AF, Badr EE: Value of first-trimester serum lipid profile in early prediction of preeclampsia and its severity: A prospective cohort study. Hypertens Pregnancy 2016, 35(1):73–81. pmid:26829675
  26. 26. Enaruna NO, Idemudia JO, Aikoriogie PI: Serum lipid profile and uric acid levels in preeclampsia in University of Benin Teaching Hospital. Nigerian medical journal: journal of the Nigeria Medical Association 2014, 55(5):423–427. pmid:25298609
  27. 27. Irinyenikan TA, Arowojolu A, Olayemi O: Comparative study of serum lipid levels in normotensive and pre-eclamptic Nigerian women. International Journal of Medicine and Biomedical Research 2014, 3(2):137–145.
  28. 28. Nyam YE, Anzaku AS, Gamece MI, Haruna DP: A study of maternal serum lipids in pregnancies complicated by pre-eclampsia in a cohort of Nigerian women. Science Research 2014, 2(6):150–154.
  29. 29. Ephraim R, Doe P, Amoah S, Antoh E: Lipid Profile and High Maternal Body Mass Index is Associated with Preeclampsia: A Case-Control Study of the Cape Coast Metropolis. Ann Med Health Sci Res 2014, 4(5):746–750. pmid:25328787
  30. 30. Onuegbu AJ, Olisekodiaka JM, Udo JU, Umeononihu O, Amah UK, Okwara JE, et al.: Evaluation of high-sensitivity C-reactive protein and serum lipid profile in southeastern Nigerian women with pre-eclampsia. Medical principles and practice: international journal of the Kuwait University, Health Science Centre 2015, 24(3):276–279. pmid:25896579
  31. 31. Abubakar A, Mabrouk M, Girei AB, Ahmed MK: Lipid Profiles and Platelets Counts of Pre-eclamptic women in Selected Rural Areas of Northern Nigeria. WebmedCentral 2011, WMC002121:1–61. pmid:21587344
  32. 32. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA: Pathophysiology of Hypertension During Preeclampsia Linking Placental Ischemia With Endothelial Dysfunction. Hypertension 2001, 38(2):718–722. pmid:11566964
  33. 33. Gohil JT, Patel PK, Gupta P: Estimation of lipid profile in subjects of preeclampsia. Journal of obstetrics and gynaecology of India 2011, 61(4):399–403. pmid:22851820
  34. 34. Anand S, Young SA, Esplin SM, Peaden B, Tolley DH, Porter FT, et al.: Detection and confi rmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry. Journal of lipid research 2016, 57:687–696. pmid:26891737
  35. 35. Basaran A: Pregnancy-induced hyperlipoproteinemia: review of the literature. Reproductive sciences (Thousand Oaks, Calif) 2009, 16(5):431–437. pmid:19233944
  36. 36. Spracklen CN, Smith CJ, Saftlas AF, Robinson JG, Ryckman KK: Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. American journal of epidemiology 2014, 180(4):346–358. pmid:24989239
  37. 37. Jasovic-Siveska E, Milkovski D: Maternal plasma lipid concentration in first and second trimester of pregnancy and risk of preeclampsia. Obstetrics & Gynecology International Journal 2019, 10(4).
  38. 38. Mittal M, Kulkarni CV, Panchonia A, Mittal RK: Evaluation of serum lipid profile in cases of pre-eclampsia and eclampsia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2014, 3(3):732–734.
  39. 39. Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, et al.: Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth 2016, 16:60. pmid:27000102
  40. 40. Adank MC, Benschop L, Peterbroers KR, Smak Gregoor AM, Kors AW, Mulder MT, et al.: Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long term postpartum? Am J Obstet Gynecol 2019, 221(2):150 e151–150 e113. pmid:30940559
  41. 41. Herrera E, Desoye G: Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm Mol Biol Clin Investig 2016, 26(2):109–127. pmid:26351960
  42. 42. Herrera E, Ortega-Senovilla H: Maternal lipid metabolism during normal pregnancy and its implications to fetal development. Clinical Lipidology 2010, 5(6):899–911.
  43. 43. Talayero BG, Sacks FM: The role of triglycerides in atherosclerosis. Curr Cardiol Rep 2011, 13(6):544–552. pmid:21968696
  44. 44. Landmesser U, Hazen S: HDL-cholesterol, genetics, and coronary artery disease: the myth of the 'good cholesterol'? Eur Heart J 2018, 39(23):2179–2182. pmid:29905819
  45. 45. Flaquer A, Rospleszcz S, Reischl E, Zeilinger S, Prokisch H, Meitinger T, et al.: Mitochondrial GWA Analysis of Lipid Profile Identifies Genetic Variants to Be Associated with HDL Cholesterol and Triglyceride Levels. PloS one 2015, 10(5):e0126294. pmid:25945934
  46. 46. Choudhury KN, Mainuddin AK, Wahiduzzaman M, Islam SM: Serum lipid profile and its association with hypertension in Bangladesh. Vascular health and risk management 2014, 10:327–332. pmid:25061312
  47. 47. Busso D, Rigotti A: Blood lipids during pregnancy: A progressively appreciated subject in basic and clinical research. Atherosclerosis 2018, 276:163–165. pmid:30001810
  48. 48. Goldstein JL, Brown MS: A century of cholesterol and coronaries: from plaques to genes to statins. Cell 2015, 161(1):161–172. pmid:25815993